Chronic HBV was associated with increased risk for adverse COVID-19 outcomes, but the risk was lower among coinfected patients vaccinated against COVID-19.

Fatigue and yellowing eyes may signal hepatitis, a serious liver issue. Learn the symptoms, causes, prevention, and available ...

Gain valuable insights into novel therapies, ongoing clinical trials, and future innovations shaping the treatment of ...

Most patients recovering from acute hepatitis B clear HBsAg within 4-6 months after onset of infection; however, persistence of HBsAg for more than 6 months refers to chronic HBV infection.

PBGENE-HBV is designed to potentially cure chronic hepatitis B by eliminating the root cause of the virus. The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an ...

The company is dedicated to educating patients, providers, and others on new findings in chronic hepatitis B virus (HBV) infection. Chronic HBV infection is the most common viral infection in ...

The management of chronic hepatitis B (CHB) during pregnancy remains a challenge and involves various aspects of maternal-fetal care. Despite the standard immunoprophylaxis, a significant portion ...

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

The hepatitis B virus can cause a mild, temporary (acute) illness or a serious, lifelong (chronic) disease. An estimated 880,000 to 1.89 million people in the United States have chronic hepatitis ...

Liver fibrosis is a key process in the progression of chronic liver diseases. However, there are currently no drugs ...

China: A recent retrospective cohort study has highlighted the significant role of pulmonary infections in influencing ...